--- title: 'Director, Marketing Operations at Summit Therapeutics' canonical: 'https://feeny.ai/job/director-marketing-operations-summit-therapeutics-princeton-5kjc188q3z1y' type: 'job' last_seen: '2026-09-04' --- # Director, Marketing Operations at Summit Therapeutics - **Company:** Summit Therapeutics - **Location:** Princeton, NJ - **Compensation:** $203k–$253k - **Posted:** 2026-09-03 - **Last confirmed live:** 2026-09-04 - **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4393702009 ## Job description About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Location: Princeton, NJ onsite Overview of Role: The Director, Marketing Operations partners with the marketing leaders to operationalize their initiatives, taking the plans Marketing sets and turning them into work that is executable, compliant, measurable, and on budget. The Director, Marketing Operations  supports the Market Access team by running their materials through the promotional review committee (PRC) and handling the production and distribution behind them, owns meetings and events coordination for the commercial organization, owns budget management for marketing operations , a Role and Responsibilities: - Owns marketing operational infrastructure including the promotional review committee (PRC) workflow and the content lifecycle behind it, promotional material fulfillment and warehousing, speaker program and event operations, meetings and events coordination across the commercial organization, agency and vendor management, budget management, and marketing performance reporting. - Partner with the marketing leaders to operationalize their initiatives. Operationalize omnichannel initiatives across email, web, digital, and field channels, including campaign build, deployment, scheduling, and the operational support behind each launch, working from the plans and content Marketing provides. - Own speaker program operations in support of the programs Marketing designs, including the speaker program management platform, speaker contracting workflow, and vendor management, with compliance built into the process. - Own events, exhibits, and sponsorship operations for the events Marketing and the field commit to, including the management platform, vendor relationships, and cross-team coordination. - Own promotional material fulfillment, including the warehouse and fulfillment vendor, print production, drop shipping to the field, and inventory control. - Lead promotional review and content operations, partnering cross-functionally with Marketing, Medical, Legal, Regulatory, Compliance, Commercial, and external agencies to ensure timely, compliant review and approval of promotional and market access materials. - Establish and optimize commercial operating processes, including SOPs, workflows, capacity planning, training, and performance metrics to improve efficiency, reduce rework, and accelerate time to market. - Oversee marketing technology and content management capabilities, serving as the business owner for platforms supporting promotional review, digital asset management, marketing automation, and commercial engagement. Partner with technology teams to define requirements, implement enhancements, and drive user adoption. - Develop commercial performance reporting and insights, partnering with Commercial Analytics and Sales Operations to establish KPIs, monitor performance, and support data-driven marketing and field execution. - Lead commercial meetings, events, and advisory board operations, overseeing planning, vendors, budgets, logistics, and execution while ensuring appropriate compliance and governance. - Manage marketing operations vendors and agency relationships, including strategic partner management, contracts, scopes of work, performance, and operational delivery. - Own marketing operations financial management, including annual budgeting, forecasting, spend tracking, vendor commitments, and financial reporting in partnership with Finance. - Provide strategic operational leadership across the commercial organization, identifying gaps, establishing scalable processes, managing cross-functional priorities, and ensuring activities comply with applicable regulations, company policies, and legal requirements. - Manage the end-to-end PRC process, including quality control and compliance-readiness review of promotional materials; intake, submission, version control, agenda development, meeting facilitation, approval tracking, reviewer feedback incorporation, distribution, and expiration within Veeva Vault PromoMats or equivalent systemsAll other duties as assigned Experience, Education and Specialized Knowledge and Skills: - Bachelor's degree in Business, Marketing, or a related field. MBA preferred. - Minimum of 10+ years of marketing operations, commercial operations, or commercial content operations experience within pharmaceuticals, biotechnology, or life sciences, including 2+ years of people or vendor team leadership. - Demonstrated expertise coordinating promotional review committee or medical, legal and regulatory review processes in a regulated pharmaceutical environment is required. - Hands-on experience with marketing technology platforms, Veeva Vault PromoMats or an equivalent electronic review and content management system is required. - Working knowledge of FDA promotional regulations and OPDP submission requirements, including Form 2253. - Experience writing and maintaining standard operating procedures for commercial content, and training users on them. - Familiarity with modular content strategy, digital asset management, and content taxonomy. - Demonstrated ability to lead without direct authority across Marketing, Medical, Legal, Regulatory, and agency partners. - Experience standing up a promotional review workflow and managing content through review, approval, distribution, and expiration. - Demonstrated experience planning and executing commercial meetings and events, including national sales meetings, congresses, and exhibits, with responsibility for budget and on-site execution. - Experience supporting a market access or payer team, including moving payer-facing materials through a promotional or medical review process. - Demonstrated experience owning and managing a departmental budget, including purchase order management, accruals, invoice reconciliation, and monthly variance reporting to Finance. - Working knowledge of compliance and regulatory requirements governing pharmaceutical promotion, including Sunshine Act reporting obligations tied to speaker programs. - Product launch experience preferred. - Oncology experience preferred. This is the pay for this position Pay Transparency $203,000—$253,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. ## About Summit Therapeutics ## Company Overview - **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors. - **Entity Type**: Public (NASDAQ: SMMT) - **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland) - **Founded**: 2003 - **Founders**: Not publicly disclosed on the company website; the company was founded in 2003. ## Core Business - **Primary industry**: Biopharmaceuticals / Oncology - **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology - **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx) ## Products & Services - **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx) ## Market Standing - **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings. - **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors. - **Growth Signals**: - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE). - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx) - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) ## Competitive Advantages - **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies. - **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials. - **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world. - **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline. ## Strategic Focus - **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization. - **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player. - **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure. ## Why Work Here - **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) - **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives." - **Benefits (U.S.)**: - 401(k) with 6% employer match - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit - Flexible Spending Account - Commuter Benefit - Onsite lunch provided - **Benefits (U.K.)**: - Private Medical Insurance - Employee Assistance Program - Life Assurance Policy - Company Pension Contributions - ESPP - **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles. - **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics) - **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement. ## Sources 1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx) 2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx) 3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx) 4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx) 5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics) 6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics) ## Other roles at Summit Therapeutics - [Director, Commercial Analytics & Information](https://feeny.ai/job/director-commercial-analytics-information-summit-therapeutics-princeton-4sy7b3h9tjvz) — Princeton, NJ - [Project Manager - CONTRACT](https://feeny.ai/job/project-manager-contract-summit-therapeutics-princeton-nj-mjpba1rbgzgc) — Princeton NJ, United States - [Senior Manager, CRM IT](https://feeny.ai/job/senior-manager-crm-it-summit-therapeutics-princeton-nj-9q5d6bn5sa0f) — Princeton NJ, United States - [IT Business Analyst - G&A](https://feeny.ai/job/it-business-analyst-g-a-summit-therapeutics-palo-alto-8xxzscj7r2ez) — Palo Alto, CA - [IT Helpdesk Analyst](https://feeny.ai/job/it-helpdesk-analyst-summit-therapeutics-palo-alto-xkn1kh9je3fc) — Palo Alto, CA - [Associate Director, Project Management - Medical Affairs (Princeton, NJ or Palo Alto, CA)](https://feeny.ai/job/associate-director-project-management-medical-affairs-princeton-nj-or-palo-alto-h21rbxapf222) — Princeton NJ, United States - [Senior Medical Science Liaison (South)](https://feeny.ai/job/senior-medical-science-liaison-south-summit-therapeutics-united-states-jmrft1h5njy5) — United States - [Senior Medical Science Liaison (Texas)](https://feeny.ai/job/senior-medical-science-liaison-texas-summit-therapeutics-united-states-1nxejb2p96nq) — United States - [Senior Medical Science Liaison (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-northeast-summit-therapeutics-united-states-kz9wzmdv6wgq) — United States - [Senior Medical Science Liaison (Mountain West)](https://feeny.ai/job/senior-medical-science-liaison-mountain-west-summit-therapeutics-united-states-4zp7v9kdvj58) — United States